Ziemssen, T., & Gass, A. (2016). Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab. BioMed Central; Springer.
Chicago-Zitierstil (17. Ausg.)Ziemssen, Tjalf, und Achim Gass. Design of TRUST, a Non-interventional, Multicenter, 3-year Prospective Study Investigating an Integrated Patient Management Approach in Patients with Relapsing-remitting Multiple Sclerosis Treated with Natalizumab. London; Berlin; Heidelberg: BioMed Central; Springer, 2016.
MLA-Zitierstil (9. Ausg.)Ziemssen, Tjalf, und Achim Gass. Design of TRUST, a Non-interventional, Multicenter, 3-year Prospective Study Investigating an Integrated Patient Management Approach in Patients with Relapsing-remitting Multiple Sclerosis Treated with Natalizumab. BioMed Central; Springer, 2016.